Fisher Asset Management LLC Sells 70,385 Shares of The Cooper Companies, Inc. $COO

Fisher Asset Management LLC reduced its stake in shares of The Cooper Companies, Inc. (NASDAQ:COO) by 86.6% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 10,886 shares of the medical device company’s stock after selling 70,385 shares during the quarter. Fisher Asset Management LLC’s holdings in Cooper Companies were worth $892,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors have also modified their holdings of the company. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. raised its position in Cooper Companies by 48.9% in the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 22,407 shares of the medical device company’s stock worth $1,890,000 after purchasing an additional 7,363 shares during the last quarter. First Trust Advisors LP boosted its position in Cooper Companies by 115.8% in the 2nd quarter. First Trust Advisors LP now owns 136,334 shares of the medical device company’s stock valued at $9,702,000 after buying an additional 73,165 shares during the last quarter. Cresset Asset Management LLC bought a new position in Cooper Companies in the 2nd quarter valued at $291,000. Cerity Partners LLC increased its stake in shares of Cooper Companies by 4.4% in the 2nd quarter. Cerity Partners LLC now owns 17,870 shares of the medical device company’s stock valued at $1,272,000 after buying an additional 757 shares during the period. Finally, Daiwa Securities Group Inc. raised its position in shares of Cooper Companies by 2.8% during the second quarter. Daiwa Securities Group Inc. now owns 35,839 shares of the medical device company’s stock worth $2,551,000 after acquiring an additional 973 shares during the last quarter. Institutional investors and hedge funds own 24.39% of the company’s stock.

Analyst Upgrades and Downgrades

Several brokerages have recently issued reports on COO. Citigroup reaffirmed a “neutral” rating and set a $69.00 price target (down from $80.00) on shares of Cooper Companies in a research note on Thursday. Rothschild & Co Redburn cut Cooper Companies from a “buy” rating to a “neutral” rating and set a $85.00 price objective for the company. in a report on Wednesday, March 4th. Needham & Company LLC upped their target price on shares of Cooper Companies from $99.00 to $101.00 and gave the company a “buy” rating in a research report on Friday, March 6th. Wall Street Zen raised shares of Cooper Companies from a “hold” rating to a “buy” rating in a research note on Saturday, February 28th. Finally, The Goldman Sachs Group set a $61.00 price target on shares of Cooper Companies in a research report on Wednesday. One equities research analyst has rated the stock with a Strong Buy rating, eight have given a Buy rating, seven have issued a Hold rating and one has assigned a Sell rating to the company. Based on data from MarketBeat, Cooper Companies presently has an average rating of “Moderate Buy” and an average price target of $88.64.

Cooper Companies Stock Up 0.3%

NASDAQ:COO opened at $61.21 on Friday. The company has a quick ratio of 0.79, a current ratio of 1.34 and a debt-to-equity ratio of 0.22. The Cooper Companies, Inc. has a 12-month low of $58.89 and a 12-month high of $89.83. The stock’s fifty day simple moving average is $65.96 and its 200-day simple moving average is $74.87. The firm has a market capitalization of $11.94 billion, a P/E ratio of 30.30, a P/E/G ratio of 1.58 and a beta of 0.89.

Cooper Companies (NASDAQ:COO) last released its quarterly earnings data on Thursday, March 5th. The medical device company reported $1.10 EPS for the quarter, beating analysts’ consensus estimates of $1.03 by $0.07. Cooper Companies had a return on equity of 10.34% and a net margin of 9.67%.The business had revenue of $1.02 billion during the quarter, compared to the consensus estimate of $1.02 billion. During the same quarter in the prior year, the company posted $0.92 earnings per share. The firm’s revenue was up 6.2% on a year-over-year basis. Cooper Companies has set its Q2 2026 guidance at 4.580-4.660 EPS. Equities research analysts expect that The Cooper Companies, Inc. will post 4.62 earnings per share for the current year.

Cooper Companies Profile

Cooper Companies, Inc (NASDAQ: COO) is a global medical device company headquartered in San Ramon, California. Founded in 1958, the company has grown through strategic acquisitions and organic development to become a major provider of vision care and women’s health products. Cooper Companies operates through two primary business segments—CooperVision and CooperSurgical—each serving specialized markets within the healthcare industry.

The CooperVision segment develops, manufactures and markets a broad range of soft contact lenses, as well as related accessories.